Public list: Pharma Startups (4732) Cancer Therapeutics (1137)

Tyrogenex is affiliated with Xcovery Holdings. It was founded by Sheridan (Sherry) Snyder through Biocatalyst International in partnership with Dr. Chris Liang. Through this partnership, Tyrogenex has developed a novel, patented cancer therapeutic, X-82. The compound, a dual VEGFR/PDGFR inhibitor, is being studies in a clinical trial for the treatment of advanced solid tumors.

Tyrogenex is affiliated with Xcovery Holdings. It was founded by Sheridan (Sherry) Snyder through Biocatalyst International in partnership with Dr. Chris Liang. Through this partnership, Tyrogenex has developed a novel, patented cancer therapeutic, X...Show all

Company (Alive / Active)

Phone: 561-406-9700

Fax:

11780 U.S. Hwy One
Suite 202
North Palm Beach, 33408
Florida, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Tyrogenex $29.6M Feb 26, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Tyrogenex Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Kinase inhibitor compounds Jan 12, 2012 Sep 03, 2013 Patent
Kinase inhibitor compounds Jan 28, 2010 Oct 18, 2011 Patent
Kinase inhibitor compounds Dec 28, 2007 Mar 23, 2010 Patent